Comerica Bank’s SpringWorks Therapeutics SWTX Stock Holding History

Comerica Bank’s Portfolio SWTX Stock Details SWTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-169	Closed	-$7.94K	–	3806
2025 Q2	$7.94K	Sell	169 -1,481	-90%	-$65.9K	﹤0.01%	3268
2025 Q1	$72.8K	Buy	1,650 +118	+8%	+$5.43K	﹤0.01%	2688
2024 Q4	$55.3K	Sell	1,532 -154	-9%	-$5.38K	﹤0.01%	2773
2024 Q3	$54K	Buy	1,686 +10	+0.6%	+$374	﹤0.01%	2769
2024 Q2	$63.1K	Buy	1,676 +464	+38%	+$19.5K	﹤0.01%	2682
2024 Q1	$59.7K	Buy	1,212 +80	+7%	+$3.7K	﹤0.01%	2708
2023 Q4	$41.3K	Sell	1,132 -322	-22%	-$8.4K	﹤0.01%	2777
2023 Q3	$33.6K	Sell	1,454 -3,108	-68%	-$85K	﹤0.01%	2823
2023 Q2	$85	Buy	+4,562	New	+$120K	0.01%	127

Other funds holding SWTX

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Comerica Bank's SWTX Position: Q3 2025 in Review

Comerica Bank sold out of SpringWorks Therapeutics (SWTX) in Q3 2025, closing a stake of 169 shares — an estimated $7.94K sold.

Comerica Bank first reported a position in SWTX in Q2 2023 and held it in 9 quarters. The position peaked at $72.8K in Q1 2025. 3 funds tracked by Wall St. Rank hold SWTX as of Q3 2025.

Comerica Bank reported no remaining SpringWorks Therapeutics position as of Q3 2025 after selling out during the quarter.
Comerica Bank sold 169 SpringWorks Therapeutics shares in Q3 2025, an estimated $7.94K.
Comerica Bank first reported a position in SpringWorks Therapeutics in Q2 2023 and held it in 9 quarters.
Comerica Bank's SpringWorks Therapeutics position peaked at $72.8K in Q1 2025.
3 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q3 2025.

Based on Comerica Bank's 13F filing for Q3 2025, filed 14 Nov 2025.